New! Sign up for our email newsletter on Substack.

Denmark cuts ART reimbursement under new savings scheme

‘This is sad news considering Denmark has always been praised as the benchmark in Europe in terms of access and availability of treatment for patients seeking ART’ said Dr. Søren Ziebe from the University Hospital in Copenhagen, Executive Committee Member of ESHRE and the SIG coordinator of all SIGs at ESHRE.

Denmark until now provided reimbursement for assisted reproduction treatments (ART) with up to three treatment trials for married and unmarried couples, singles and homosexuals.

The Danish government has allocated a pool of a mere 50 million Danish Krone (approximately 6.7 million Euros) for groups with special needs only. The cuts in this area will decrease government spending by 200 million Danish Krone (EUR 26.9 million) annually in 2011, 2012, 2013 and thereafter.

In 2007, 4.9% of all children born in Denmark were babies conceived with the help of ART, according to the ESHRE European IVF Monitoring Group (EIM). With 2,558 cycles per million inhabitants annually, Denmark has the highest availability of ART in Europe.

‘Every school class in Denmark has two IVF children on average’ said Dr. Ziebe. ‘These changes will have major implications and detrimental effect for childless couples, for fertility clinics and the research environment in Denmark.’

For more information please view the document released by the Danish authorities (in Danish only) at: http://www.eshre.eu/page.aspx/1020.

For further information you may wish to contact the Danish Minister of Health Bertel Haarder at [email protected].

Fuel Independent Science Reporting: Make a Difference Today

If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.

Join us in making knowledge accessible and impactful. Thank you for standing with us!



Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.